Drug Profile
OPC 51803
Alternative Names: SOU 003Latest Information Update: 13 Dec 2018
Price :
$50
*
At a glance
- Originator Otsuka America Pharmaceutical; Otsuka Pharmaceutical
- Class Antidiuretics; Benzazepines; Pyrrolidines
- Mechanism of Action Vasopressin V2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetes insipidus; Nocturia; Urinary incontinence
Most Recent Events
- 03 Dec 2018 Heptares Therapeutics has merged with Sosei to form Sosei Heptares
- 24 Aug 2007 Clinical development is ongoing
- 31 Jul 2006 This compound is still in active development with Sosei